Business Wire

Iktos Announce Collaboration with UCB in AI for Retrosynthesis

PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design and UCB, a global biopharma company focusing on neurology and immunology, today announced a software ...
Business Wire

Iktos Announces Collaboration With Galapagos in AI For Drug Design

PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration with Galapagos, a leading global biopharmaceutical company focused ...
Labroots

From Retrosynthesis to Reality: Interactive Pathway Design for Drug Discovery Teams w/ Live Q&A

Synthetic route design remains a critical bottleneck in small‑molecule drug discovery, especially as teams juggle complex targets, aggressive timelines, and sustainability expectations.
Times Higher Education

CBS - Postdoctoral Position, Artificial Intelligence Applied to Retrosynthesis Reaction Prediction

We are seeking a highly motivated Postdoctoral Researcher to join our interdisciplinary team focused on Artificial Intelligence (AI)-driven retrosynthesis and reaction prediction. The successful ...
Science Daily

Deep learning techniques teach neural model to 'play' retrosynthesis

Chemical engineers have trained a neural network model to plan synthetic routes to any target molecule, optimizing user-specified objectives such as cost, time, and sustainability. Researchers, from ...